Creative Financial Designs Inc. ADV Has $98,000 Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Creative Financial Designs Inc. ADV trimmed its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 51.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,258 shares of the company’s stock after selling 1,331 shares during the period. Creative Financial Designs Inc. ADV’s holdings in GE HealthCare Technologies were worth $98,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in GEHC. Empowered Funds LLC increased its position in GE HealthCare Technologies by 30.7% in the 3rd quarter. Empowered Funds LLC now owns 23,470 shares of the company’s stock valued at $2,203,000 after buying an additional 5,512 shares in the last quarter. Mutual of America Capital Management LLC increased its holdings in GE HealthCare Technologies by 5.0% during the 3rd quarter. Mutual of America Capital Management LLC now owns 56,349 shares of the company’s stock worth $5,288,000 after purchasing an additional 2,696 shares in the last quarter. Thrivent Financial for Lutherans increased its holdings in GE HealthCare Technologies by 16.5% during the 3rd quarter. Thrivent Financial for Lutherans now owns 25,408 shares of the company’s stock worth $2,385,000 after purchasing an additional 3,602 shares in the last quarter. Pathstone Holdings LLC increased its holdings in GE HealthCare Technologies by 3.2% during the 3rd quarter. Pathstone Holdings LLC now owns 33,820 shares of the company’s stock worth $3,174,000 after purchasing an additional 1,063 shares in the last quarter. Finally, Prospera Financial Services Inc increased its holdings in GE HealthCare Technologies by 5.3% during the 3rd quarter. Prospera Financial Services Inc now owns 5,014 shares of the company’s stock worth $471,000 after purchasing an additional 253 shares in the last quarter. 82.06% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have commented on GEHC shares. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. Citigroup boosted their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, Wells Fargo & Company upped their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, February 14th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $98.75.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $81.81 on Friday. GE HealthCare Technologies Inc. has a 12 month low of $74.51 and a 12 month high of $94.80. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The business’s 50 day simple moving average is $87.08 and its 200 day simple moving average is $86.05. The company has a market cap of $37.41 billion, a price-to-earnings ratio of 18.89, a PEG ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.